Kiyotoshi Imai
- Hematology top 2%
- Oncology
- Public Health, Environmental and Occupational Health top 10%
- Molecular Biology
- Immunology
- Co-authors
- Junji TanakaMasanobu KobayashiJunichi HamadaMasahiro AsakaMasahiro ImamuraYoshiko AtsutaManabu MusashiMasanobu SHINDO
- Topics
- Chronic Myeloid Leukemia Treatments (12 papers)Acute Lymphoblastic Leukemia research (12 papers)Eosinophilic Disorders and Syndromes (6 papers)
- Partner nations
- JapanSlovakiaUnited States
In The Last Decade
Kiyotoshi Imai
31 papers receiving 641 citations
Peers
Comparison fields: 5 of 74
- Hematology 394
- Oncology 200
- Public Health, Environmental and Occupational Health 181
- Molecular Biology 122
- Immunology 120
Countries citing papers authored by Kiyotoshi Imai
This map shows the geographic impact of Kiyotoshi Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyotoshi Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyotoshi Imai more than expected).
Fields of papers citing papers by Kiyotoshi Imai
This network shows the impact of papers produced by Kiyotoshi Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyotoshi Imai. The network helps show where Kiyotoshi Imai may publish in the future.
Co-authorship network of co-authors of Kiyotoshi Imai
This figure shows the co-authorship network connecting the top 25 collaborators of Kiyotoshi Imai. A scholar is included among the top collaborators of Kiyotoshi Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyotoshi Imai. Kiyotoshi Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 58 | |
| 4 | 1 | |
| 5 | 24 | |
| 6 | 9 | |
| 7 | 21 | |
| 8 | 10 | |
| 9 | 22 | |
| 10 | 32 | |
| 11 | 9 | |
| 12 | 0 | |
| 13 | 82 | |
| 14 | 0 | |
| 15 | 19 | |
| 16 | 100 | |
| 17 | 5 | |
| 18 | 9 | |
| 19 | 13 | |
| 20 | Expression of two types of kit ligand mRNAs in human tumor cells. | 3 |
About Kiyotoshi Imai
Kiyotoshi Imai is a scholar working on Hematology, Immunology and Allergy and Genetics, having authored 35 papers that have together received 655 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (12 papers), Acute Lymphoblastic Leukemia research (12 papers) and Eosinophilic Disorders and Syndromes (6 papers). The work is most often cited by research in Hematology (394 citations), Biochemistry (71 citations) and Immunology and Allergy (71 citations). Kiyotoshi Imai has collaborated with scholars based in Japan, Slovakia and United States. Frequent co-authors include Junji Tanaka, Masanobu Kobayashi, Junichi Hamada, Masahiro Asaka, Masahiro Imamura, Yoshiko Atsuta, Manabu Musashi, Masanobu SHINDO, Fumihiro Higashino and Yuko Cho. Their work appears in journals such as Blood, Annals of Oncology and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.